Coate B - Search Results

1

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

Zorrilla CD, Wright R, Osiyemi OO, Yasin S, Baugh B, Brown K, Coate B, Verboven P, Mrus J, Falcon R, Kakuda TN. Zorrilla CD, et al. Among authors: coate b. HIV Med. 2014 Jan;15(1):50-6. doi: 10.1111/hiv.12047. Epub 2013 Jun 3. HIV Med. 2014. PMID: 23731450 Free PMC article. Clinical Trial.

2

The Intelence aNd pRezista Once A Day Study (INROADS): a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects.

Ruane PJ, Brinson C, Ramgopal M, Ryan R, Coate B, Cho M, Kakuda TN, Anderson D; INROADS study investigators. Ruane PJ, et al. Among authors: coate b. HIV Med. 2015 May;16(5):288-96. doi: 10.1111/hiv.12211. Epub 2015 Jan 14. HIV Med. 2015. PMID: 25585528 Free article. Clinical Trial.

3

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial.

Overton ET, Tebas P, Coate B, Ryan R, Perniciaro A, Dayaram YK, De La Rosa G, Baugh BP. Overton ET, et al. Among authors: coate b. HIV Clin Trials. 2016 Mar;17(2):72-7. doi: 10.1080/15284336.2016.1141468. HIV Clin Trials. 2016. PMID: 26917112 Free PMC article. Clinical Trial.

4

Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial.

Kakuda T, Sekar V, Vis P, Coate B, Ryan R, Anderson D, De La Rosa G, Mrus J. Kakuda T, et al. Among authors: coate b. AIDS Res Treat. 2012;2012:186987. doi: 10.1155/2012/186987. Epub 2012 Mar 21. AIDS Res Treat. 2012. PMID: 22536495 Free PMC article.

5

Health-related quality of life in the gender, race, and clinical experience trial.

Feinberg J, Saag M, Squires K, Currier J, Ryan R, Coate B, Mrus J. Feinberg J, et al. Among authors: coate b. AIDS Res Treat. 2011;2011:349165. doi: 10.1155/2011/349165. Epub 2011 Aug 28. AIDS Res Treat. 2011. PMID: 21904672 Free PMC article.

6

Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients.

Zeuzem S, DeMasi R, Baldini A, Coate B, Luo D, Mrus J, Witek J. Zeuzem S, et al. Among authors: coate b. J Hepatol. 2014 Jun;60(6):1112-7. doi: 10.1016/j.jhep.2014.01.013. Epub 2014 Jan 29. J Hepatol. 2014. PMID: 24486089 Clinical Trial.

7

Outcomes in older versus younger patients over 96 weeks in HIV-1- infected patients treated with rilpivirine or efavirenz in ECHO and THRIVE.

Ryan R, Dayaram YK, Schaible D, Coate B, Anderson D. Ryan R, et al. Among authors: coate b. Curr HIV Res. 2013 Oct;11(7):570-5. doi: 10.2174/1570162x12666140128121900. Curr HIV Res. 2013. PMID: 24467642 Free PMC article. Clinical Trial.

8

Week 96 outcomes of patients with less treatment experience versus more treatment experience receiving etravirine in the DUET trials.

Anderson D, DeMasi R, DeLaitsch L, Surles T, Coate B. Anderson D, et al. Among authors: coate b. Curr HIV Res. 2012 Apr;10(3):256-61. doi: 10.2174/157016212800618110. Curr HIV Res. 2012. PMID: 22497697 Clinical Trial.

9

Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.

Younossi Z, Negro F, Serfaty L, Pol S, Diago M, Zeuzem S, Andreone P, Lawitz EJ, Roberts S, Focaccia R, Foster GR, Horban A, Lonjon-Domanec I, Coate B, DeMasi R, Picchio G, Witek J. Younossi Z, et al. Among authors: coate b. Hepatology. 2013 Dec;58(6):1897-906. doi: 10.1002/hep.26437. Epub 2013 Oct 17. Hepatology. 2013. PMID: 24382638 Clinical Trial.

10

An Open-Label, 8-Week Study of Safety and Efficacy of Pimavanserin Treatment in Adults with Parkinson's Disease and Depression.

DeKarske D, Alva G, Aldred JL, Coate B, Cantillon M, Jacobi L, Nunez R, Norton JC, Abler V. DeKarske D, et al. Among authors: coate b. J Parkinsons Dis. 2020;10(4):1751-1761. doi: 10.3233/JPD-202058. J Parkinsons Dis. 2020. PMID: 32804101 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters